Delcath Systems, Inc. DCTH NASDAQ · Healthcare · United States
$19.70 +1.70% +$0.33
Summary
58 / 100 · Bulios Score
What speaks for it
- Revenue grew by 215% a year over the last 3 years.
- It holds more cash than debt: $55.5M against $2.41M.
- Out of every 100 USD of revenue, 18 USD is left as free cash.
What to watch
- The share price is above the Bulios Fair Price.
- It earns only 3.1 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 101.3 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 120% a year over 5 years. Over the last 3 years it grew by 215% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 12 USD
- Research and development 37 USD
- Sales and administration 46 USD
- Taxes and other -0.9 USD
- Net profit 6.1 USD
Net profit, industry median (Medical - Devices) 6.9 USD
Out of every 100 USD of revenue, 6.1 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 8
- Hold 2
- Sell 1
Today's price within the analysts' price targets
The average target of $28.5 is 45% above today's price. 73% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2023By product
- Product 100%
By region
- UNITED STATES 92%
- Non-US 7.5%
Product brings in 100% of revenue.
Segments in detail